Skip to main content
. 2021 Mar 16;7(3):e06255. doi: 10.1016/j.heliyon.2021.e06255

Figure 1.

Figure 1

Western bloting of Cas-3, P53, PARP and Actin in HL60/ADR after co-treatment of 0.1 μg/ml of doxirubcin with (100, 250, 500, and 1000 μg/ml) coumarin) and (B-E) a quantification of western blot data using Image J softrware.